Related Experiment Videos
Nonrespiratory complications of M. pneumoniae infection
1University of California, San Diego.
Abstract:
Mycoplasma pneumoniae infection occurs in more than 10 million Americans each year. Most patients have a mild respiratory illness; only 5 percent develop clinical pneumonia. Nonrespiratory complications may involve skin, joints, central nervous system, heart, liver, kidneys or blood; some lead to significant morbidity and mortality. Immune-inflammatory responses appear to be the cause of these manifestations.
Insights
Mycoplasma pneumoniae infections affect millions annually, often causing mild respiratory illness. However, immune responses can trigger severe nonrespiratory complications impacting multiple organs, leading to significant illness and death.
Area of Science:
- Infectious Diseases
- Immunology
- Pulmonology
Background:
- Mycoplasma pneumoniae is a common pathogen causing over 10 million infections in Americans yearly.
- While typically causing mild respiratory illness, a small percentage of patients develop pneumonia.
- Extrapulmonary manifestations can affect various organ systems, contributing to significant morbidity and mortality.
Purpose of the Study:
- To summarize the epidemiology and clinical spectrum of Mycoplasma pneumoniae infections.
- To highlight the potential for severe nonrespiratory complications.
- To underscore the role of immune-inflammatory responses in disease pathogenesis.
Main Methods:
- Review of existing epidemiological data on Mycoplasma pneumoniae infections.
- Analysis of clinical case studies detailing respiratory and nonrespiratory complications.
- Discussion of immunological mechanisms implicated in Mycoplasma pneumoniae pathogenesis.
Main Results:
- Over 10 million Mycoplasma pneumoniae infections occur annually in the US.
- Only 5% of infected individuals develop clinical pneumonia.
- Nonrespiratory complications involve skin, joints, CNS, heart, liver, kidneys, and blood, with some cases resulting in high morbidity and mortality.
Conclusions:
- Mycoplasma pneumoniae infections represent a significant public health burden.
- Immune-inflammatory responses are critical in the development of nonrespiratory complications.
- Understanding these mechanisms is crucial for managing severe cases and improving patient outcomes.